Home › Funds › Decheng Capital LLC › RVMD

Decheng Capital LLC position in RVMD

REVOLUTION MEDICINES INC · Health Care

Decheng Capital LLC reported holding 52,667 shares of RVMD (REVOLUTION MEDICINES INC) in its Q2 2026 13F filing — a position valued at US$9.9M, representing 1.35% of its reported portfolio and ranking #8 among its reported holdings. Decheng Capital LLC has disclosed RVMD holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)52.67K sh
Reported value held$9.86M
Portfolio Weight1.35%
First reportedQ3 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Decheng Capital LLC's RVMD position evolved

Decheng Capital LLC first disclosed a stake in RVMD in Q3 2024 at 2,000 shares (US$91K). The position peaked in Q4 2025 at 200,000 shares, worth US$15.9M. Across 8 filings, Decheng Capital LLC increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 52,667 shares valued at US$9.9M — a reduction of -40,833 shares quarter over quarter.. Notable position changes include a 11200% increase in Q4 2024 (shares fell 19% over the following quarter), a 53% trim in Q1 2026 (shares rose 93% over the following quarter), a 44% trim in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 2.00K $90.70K New
Q4 2024 226.00K $9.89M Add
Q1 2025 226.00K $7.99M Hold
Q2 2025 226.00K $8.31M Hold
Q3 2025 210.00K $9.81M Reduce
Q4 2025 200.00K $15.93M Reduce
Q1 2026 93.50K $9.09M Reduce
Q2 2026 52.67K $9.86M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RVMD and 13F data

RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 61 other funds we track also report a position in RVMD — the largest reported positions include Farallon Capital Management (US$2.54B), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RVMD

All RVMD fund holders →

FAQ

How long has Decheng Capital LLC held RVMD?

Decheng Capital LLC has disclosed RVMD holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Decheng Capital LLC's current position in RVMD?

As of Q2 2026, Decheng Capital LLC holds 52.67K shares of RVMD (REVOLUTION MEDICINES INC), valued at $9.86M, representing 1.35% of its reported portfolio and ranking #8.

Has Decheng Capital LLC been buying or selling RVMD?

In the latest 13F filing (Q2 2026), Decheng Capital LLC reduced its position in RVMD. The position peaked in Q4 2025 at 200.00K shares.

Which other funds hold RVMD?

Other major institutional holders of RVMD include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.